VANCOUVER, British Columbia — August 18, 2025 — Leads & Copy — Treatment.com AI Inc. is rebranding as Rocket Doctor AI Inc., effective August 21, 2025, and will trade on the Canadian Securities Exchange under the ticker AIDR. The rebrand unites the company’s Global Library of Medicine (GLM) with Rocket Doctor Inc’s digital health platform, delivering AI-enhanced clinical and diagnostic tools.
The company is leveraging large language models, connected medical devices, and proprietary software to improve healthcare access for rural, remote, and underserved communities across North America. The rebranding builds on the acquisition of Rocket Doctor Inc. in April 2025.
The new CUSIP number is 772924106 and the ISIN number is CA7729241066 for the Company’s common shares. The new stock symbol, AIDR, is intended to better represent the Company’s core focus on AI-driven administrative, diagnostic, clinical decision support and referral solutions that empower both healthcare professionals and patients.
Dr. Essam Hamza, CEO of Treatment.com AI Inc., said the name change marks a natural step in uniting the company’s technology and service offerings. Dr. William Cherniak, CEO of Rocket Doctor Inc., said the refined name makes clear the company’s focus on technology as a component to improving physicians’ practice of medicine, while in parallel increasing access to care for patients in need.
Dr. Essam Hamza, CEO, ehamza@treatment.com, +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Dr. Bill Cherniak, CEO, Rocket Doctor, Email: bill@rocketdoctor.io
